Correlation Between Sprint Bioscience and Xbrane Biopharma
Can any of the company-specific risk be diversified away by investing in both Sprint Bioscience and Xbrane Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sprint Bioscience and Xbrane Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sprint Bioscience AB and Xbrane Biopharma AB, you can compare the effects of market volatilities on Sprint Bioscience and Xbrane Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sprint Bioscience with a short position of Xbrane Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sprint Bioscience and Xbrane Biopharma.
Diversification Opportunities for Sprint Bioscience and Xbrane Biopharma
0.72 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Sprint and Xbrane is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding Sprint Bioscience AB and Xbrane Biopharma AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Xbrane Biopharma and Sprint Bioscience is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sprint Bioscience AB are associated (or correlated) with Xbrane Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Xbrane Biopharma has no effect on the direction of Sprint Bioscience i.e., Sprint Bioscience and Xbrane Biopharma go up and down completely randomly.
Pair Corralation between Sprint Bioscience and Xbrane Biopharma
Assuming the 90 days trading horizon Sprint Bioscience AB is expected to generate 0.32 times more return on investment than Xbrane Biopharma. However, Sprint Bioscience AB is 3.16 times less risky than Xbrane Biopharma. It trades about 0.03 of its potential returns per unit of risk. Xbrane Biopharma AB is currently generating about -0.01 per unit of risk. If you would invest 183.00 in Sprint Bioscience AB on September 1, 2024 and sell it today you would lose (1.00) from holding Sprint Bioscience AB or give up 0.55% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Sprint Bioscience AB vs. Xbrane Biopharma AB
Performance |
| Timeline |
| Sprint Bioscience |
| Xbrane Biopharma |
Sprint Bioscience and Xbrane Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Sprint Bioscience and Xbrane Biopharma
The main advantage of trading using opposite Sprint Bioscience and Xbrane Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sprint Bioscience position performs unexpectedly, Xbrane Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Xbrane Biopharma will offset losses from the drop in Xbrane Biopharma's long position.| Sprint Bioscience vs. Kancera AB | Sprint Bioscience vs. Cyxone AB | Sprint Bioscience vs. Lidds AB | Sprint Bioscience vs. Cantargia AB |
| Xbrane Biopharma vs. Kancera AB | Xbrane Biopharma vs. Cyxone AB | Xbrane Biopharma vs. Lidds AB | Xbrane Biopharma vs. Cantargia AB |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |